Skip to content

Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer

Building Family Caregiver Skills Using a Simulation-based Intervention for Care of Patients With Head and Neck Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02577237
Enrollment
18
Registered
2015-10-16
Start date
2015-08-01
Completion date
2018-01-12
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

caregiver, simulation

Brief summary

Patients with head and neck cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study tests whether different forms of education and support can help family caregivers feel better prepared. To find out if education about caregiving and different kinds of support are effective, this study wants to compare approaches.One group includes caregivers who will receive an education and support program throughout radiation treatment in addition to usual care by their doctors and nurses. The other group receives an educational booklet about caregiving in addition to usual care by their doctors and nurses. The caregiver also completes surveys about his or her emotions, distress, confidence as a care giver, and quality of life. In addition, the study asks the caregiver questions about his or her age, race, ethnicity, marital status, employment status, education, annual household income, and current living arrangements. This pilot study will only be offered at the Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Main Campus.

Detailed description

Aim 1: Conduct a pilot test of the effects of a novel caregiver intervention, as compared to a control group, on family caregiver self-efficacy for caregiving, anxiety, depression, and health-related quality of life. Aim 2: Explore the acceptability of a caregiver intervention that utilizes simulation. Aim 3: Assess the feasibility of the intervention. Aim 4: Describe the incidence of patient events that may be impacted by caregiver self-efficacy, such as acute care visits, admissions to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course.

Interventions

BEHAVIORALIn-person education sessions

The intervention will be delivered by a radiation oncology nurse. Each of the four in-person sessions consists of approximately 30 minutes of educational content/simulation that addresses a specific caregiving topic and any issues or concerns that the caregiver may be experiencing.

BEHAVIORALNCI Booklet

Radiation Oncology Nurse will hand participant the NCI booklet

OTHERSurvey

written, qualitative assessments of areas including depression and anxiety, caregiver self-efficacy, care-giver self efficacy for head and neck cancer, health-related quality of life, patient performance status, demographics, and medical history.

OTHERInterview

A structured series of open-ended questions will be used during a telephone interview with participants at four weeks post radiation treatment.

Sponsors

Case Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* family member or friend of an adult patient with a new diagnosis of Stage III - IV cancers of the tongue, gum, oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, or parotid who is receiving radiation therapy for curative intent * identified by the patient as his/her primary caregiver who is providing daily assistance and/or emotional support * cognitively intact, as evidenced by orientation to person, place, and time * ability to speak, read, and comprehend English

Exclusion criteria

* Caregivers of patients who are receiving hospice care will be excluded because of the patient's poor prognosis and multiple issues associated with end-of-life care * Caregivers who are themselves undergoing active cancer treatment will be excluded (hormonal treatment allowed)

Design outcomes

Primary

MeasureTime frameDescription
Average efficacy of caregiving summary scoreUp to 5 weeksSummary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
Average anxiety summary scoreUp to 5 weeksSummary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
Average depression summary scoreUp to 5 weeksSummary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
Average Health Related Quality of Life (HRQOL) summary scoreUp to 5 weeksSummary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

Secondary

MeasureTime frameDescription
Average missed checklist items to assess integrity of interventionUp to 5 weeksIntegrity of the intervention will be assessed through monitoring of intervention checklist.
Qualitative assessment of acceptabilityUp to 5 weeksDescriptive statistics will be used to summarize responses to semi-structured interviews
Event rate for patient eventsUp to 5 weeksDescribe the average incidence of all patient events that may be impacted by caregiver self-efficacy. Events may include acute care visits, admission to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course, and others
Attrition rate to assess feasibilityUp to 5 weeksFeasibility will be assessed via attrition and consent rates.
Consent rate to assess feasibilityUp to 5 weeksFeasibility will be assessed via attrition and consent rates.
Total time for delivering intervention to assess costsUp to 5 weeksTime for delivering the intervention will be recorded to aid in assessing costs.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026